Vorinostat Active Not Recruiting Phase 1 Trials for Plasma Cell Neoplasms / Multiple Myeloma (MM) Treatment

Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00729118Vorinostat and Lenalidomide After Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT01038388A Study of the Combination Vorinostat With Lenalidomide, Bortezomib and Dexamethasone for Patients With Newly Diagnosed Multiple Myeloma